文献速递外周血管技术与安全MR

锰基钆替代对比剂:对比增强MR血管成像、排泄、药代动力学与代谢

A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
PubMed 文献 · Radiology · 2017-11-08

本研究在狒狒体内比较锰基对比剂Mn-PyC3A与钆喷酸葡胺的血管内对比增强效果,并评估其排泄、药代动力学与代谢;结果显示两者在腹主动脉和头臂动脉的对比噪声比无显著差异,Mn-PyC3A经肾和肝胆排泄、药代动力学与钆喷酸葡胺相似,且高效液相色谱未发现生物转化证据。

要点

  • Mn-PyC3A增强MR血管成像的血管-肌肉对比噪声比与钆喷酸葡胺相当,腹主动脉P=0.11、头臂动脉P=0.95。
  • Mn-PyC3A经肾脏和肝胆途径排泄,其药代动力学与钆喷酸葡胺相似。
  • 高效液相色谱未发现Mn-PyC3A生物转化证据。

核心结论

  • Mn-PyC3A可实现与钆基对比剂相当的对比增强MR血管成像,并可能消除对钆相关毒性和滞留的担忧。

研究设计与样本

  • 在4只狒狒(Papio anubis)中分别使用Mn-PyC3A和钆喷酸葡胺进行对比增强MR血管成像,注射后动态成像60分钟,连续采血用 inductively coupled plasma mass spectrometry 定量锰和钆的血浆清除,用高效液相色谱表征Mn-PyC3A代谢,血浆药代动力学用双指数函数建模,数据用配对t检验比较。

关键影像表现/征象

  • 注射Mn-PyC3A或钆喷酸葡胺后9秒,腹主动脉对肌肉的对比噪声比(均值±标准差)分别为476±77和538±120(P=0.11)。
  • 注射Mn-PyC3A或钆喷酸葡胺后9秒,头臂动脉对肌肉的对比噪声比分别为524±55和518±140(P=0.95)。
  • Mn-PyC3A经肾脏和肝胆途径排泄。
  • 高效液相色谱未发现Mn-PyC3A生物转化的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare intravascular contrast enhancement produced by the manganese-based magnetic resonance (MR) imaging contrast agent manganese-N-picolyl-N,N',N'-trans-1,2-cyclohexenediaminetriacetate (Mn-PyC3A) to gadopentetate dimeglumine (Gd-DTPA) and to evaluate the excretion, pharmacokinetics, and metabolism of Mn-PyC3A. Materials and Methods Contrast material-enhanced MR angiography was performed in baboons (Papio anubis; n = 4) by using Mn-PyC3A and Gd-DTPA. Dynamic imaging was performed for 60 minutes following Mn-PyC3A injection to monitor distribution and elimination. Serial blood sampling was performed to quantify manganese and gadolinium plasma clearance by using inductively coupled plasma mass spectrometry and to characterize Mn-PyC3A metabolism by using high-performance liquid chromatography. Intravascular contrast enhancement in the abdominal aorta and brachiocephalic artery was quantified by measuring contrast-to-noise ratios (CNRs) versus muscle at 9 seconds following Mn-PyC3A or Gd-DTPA injection. Plasma pharmacokinetics were modeled with a biexponential function, and data were compared with a paired t test. Results Aorta versus muscle CNR (mean ± standard deviation) with Mn-PyC3A and Gd-DTPA was 476 ± 77 and 538 ± 120, respectively (P = .11). Brachiocephalic artery versus muscle CNR was 524 ± 55 versus 518 ± 140, respectively (P = .95). Mn-PyC3A was eliminated via renal and hepatobiliary excretion with similar pharmacokinetics to Gd-DTPA (area under the curve between 0 and 30 minutes, 20.2 ± 3.1 and 17.0 ± 2.4, respectively; P = .23). High-performance liquid chromatography revealed no evidence of Mn-PyC3A biotransformation. Conclusion Mn-PyC3A enables contrast-enhanced MR angiography with comparable contrast enhancement to gadolinium-based agents and may overcome concerns regarding gadolinium-associated toxicity and retention. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Gale EM, Wey HY, Ramsay I, et al. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism. Radiology. 2017. PMID: 29117483. doi:10.1148/radiol.2017170977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。